Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 24
2018 23
2019 16
2020 20
2021 9
2022 14
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2. Lancet. 2017. PMID: 28919117 Free PMC article.
Converting HIV programmes into chronic-care platforms.
Manne-Goehler J, Ogbuoji O, Bärnighausen TW. Manne-Goehler J, et al. Lancet HIV. 2020 Sep;7(9):e600-e601. doi: 10.1016/S2352-3018(20)30104-1. Lancet HIV. 2020. PMID: 32890496 Free PMC article. No abstract available.
Impact of differentiated service delivery models on retention in HIV care and viral suppression among people living with HIV in sub-Saharan Africa: A systematic review and meta-analysis of randomised controlled trials.
Bwire GM, Njiro BJ, Ndumwa HP, Munishi CG, Mpondo BC, Mganga M, Mang'ombe E, Bakari M, Sangeda RZ, Sudfeld CR, Killewo J. Bwire GM, et al. Rev Med Virol. 2023 Nov;33(6):e2479. doi: 10.1002/rmv.2479. Epub 2023 Sep 1. Rev Med Virol. 2023. PMID: 37655428 Review.
Impact of Population and Pharmacogenetics Variations on Efavirenz Pharmacokinetics and Immunologic Outcomes During Anti-Tuberculosis Co-Therapy: A Parallel Prospective Cohort Study in Two Sub-Sahara African Populations.
Mugusi S, Habtewold A, Ngaimisi E, Amogne W, Yimer G, Minzi O, Makonnen E, Sudfeld C, Burhenne J, Aklillu E. Mugusi S, et al. Front Pharmacol. 2020 Feb 7;11:26. doi: 10.3389/fphar.2020.00026. eCollection 2020. Front Pharmacol. 2020. PMID: 32116703 Free PMC article.
108 results